Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report

Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report

Abstract Background Dipeptidyl peptidase 4 inhibitor (DPP4i) is an effective medicine for type 2 diabetes mellitus (T2DM). Some articles reported DPP4i improves insulin secretion and insulin resistance. However, these effects are not well established by glucose clamp test and test meal in Japanese....

Full description

Bibliographic Details
Main Authors: Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Yuichi Ito, Sonoko Kitao, Mari Anno, Kazuhisa Matsumoto, Kyoko Shoji, Hiroko Okura, Kazuhiko Matsuzawa, Shoichiro Izawa, Etsuko Ueta, Masahiko Kato, Takeshi Imamura, Shin-ichi Taniguchi, Kazuhiro Yamamoto
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Dipeptidyl peptidase 4 inhibitor
Insulin Resistance
Type 2 Diabetes
Glucose Clamp
Online Access:https://doi.org/10.1186/s13098-022-00850-9

Internet

https://doi.org/10.1186/s13098-022-00850-9

Similar Items